AIRA MATRIX
AIRA Matrix is an India-based AI company that develops computer vision tools for digital pathology, embedding its AI into third-party platforms such as Histowiz's PathologyMap to serve pharmaceutical, biotechnology, academic, and healthcare customers globally with automated slide quality control and diagnostic support.
- Company typePrivate
- Founded2011
- HeadquartersThane, India
- Headcount101–250
- GTM typeB2B
- OfferingSoftware
What AIRA MATRIX does
AIRA Matrix is an India-based artificial intelligence company, founded in 2011 and headquartered in Thane, that develops image analysis and management solutions for preclinical toxicology and pathology applications. The company's core offering consists of computer-vision-based digital pathology tools designed to deliver automated quality control of pathology slides at a cited accuracy of over 98%, with applications spanning cancer detection, disease diagnosis, and workflow automation for pathologists. Its AI processes whole-slide pathology images to flag diagnostic and quality issues, addressing documented shortages of trained pathologists in rural and underserved settings.
The commercial model is OEM/embedded: AIRA Matrix licenses its AI tools to third-party digital pathology platform providers rather than selling directly to end users. The principal disclosed integration is with Histowiz's PathologyMap platform, through which the technology reaches pharmaceutical companies, biotechnology firms, academic institutions, and healthcare providers globally. This partner-led distribution gives the company international reach from a single India base without the cost of a direct enterprise sales motion. The company employs 101–250 people and is led by CEO Chaith Kondragunta, with founder Dilip Shanghvi, Umesh Shanghvi as Head of Innovation & Technology Development, and Nitin Singhal as Head of Products.
AIRA Matrix operates as a private, independent company. No institutional investors, funding rounds, acquisitions, subsidiaries, or regulatory certifications are disclosed in the available data. The company was recognized among the top 10 AI companies for digital pathology globally by Lumea Digital in 2024. Revenue is generated primarily through licensing and OEM integration fees, though specific contract values, customer concentration metrics, and revenue figures are not publicly disclosed.
AIRA MATRIX firmographics
Firmographics- Name
- AIRA MATRIX
- Legal name
- AIRA Matrix
- Website
- https://airamatrix.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- AIRA Matrix is an India-based AI company that develops computer vision tools for digital pathology, embedding its AI into third-party platforms such as Histowiz's PathologyMap to serve pharmaceutical, biotechnology, academic, and healthcare customers globally with automated slide quality control and diagnostic support.
- Ownership category
- akta.pro rank
AIRA MATRIX industry classification
Industry- Product category
- Digital Pathology AI Software
- NAICS
- Software Publishers (51321), Software Publishers (5132), Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays) (HLAAALAO)
- akta.pro secondary industries
- Medical Imaging AI (HDAAAEAH), AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG), Radiology AI, CAD & Advanced Visualization Software (HLAHABAJ), Domain-Specific Training Data Solutions (e.g., medical, AV, geospatial) (HDAAALAL)
Keywords
Where AIRA MATRIX is headquartered
LocationHeadquarters
- HQ city
- Thane
- HQ country
- India
- HQ region
- Asia
Offices1 record
Markets served
AIRA MATRIX business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- AI Technology Licensing and OEM Integration: AIRA Matrix generates revenue by licensing its AI technology to digital pathology platform providers. Their AI tools are embedded into third-party platforms like Histowiz's PathologyMap, making them available to pharma, biotech, and academic institutions globally. This OEM/embedded model provides recurring licensing revenue from platform integrations.
Go-to-market motion1 record
Distribution channels1 record
AIRA MATRIX product offering
Product offeringCore offering
AIRA Matrix develops and licenses AI-powered image analysis and management software for digital pathology and preclinical toxicology. Its core product consists of AI diagnostic tools that automate quality control and support cancer and disease detection on pathology slides, achieving over 98% accuracy. The tools are delivered through an OEM/embedded model into third-party digital pathology platforms such as Histowiz's PathologyMap, making them available to pharmaceutical companies, biotechnology firms, and academic institutions globally.
Product overview
AIRA Matrix is an India-based digital pathology AI company that provides AI-enabled tools for digital pathology analysis. The company's core offering consists of AI tools that integrate with platforms like PathologyMap to deliver automated quality control for pathology slides, achieving over 98% accuracy. These AI tools are made available to pharmaceutical, biotechnology, and academic institutions globally for cancer diagnostics and disease detection applications.
Differentiator
Problem solved
Functional benefit
Products and services
- AIRA Matrix AI Tools (Digital Pathology AI Suite) AI-powered software tools for digital pathology that automate quality control of pathology slides with over 98% accuracy and support cancer diagnostics and disease detection. Delivered as an OEM/embedded component inside third-party digital pathology platforms (e.g., Histowiz's PathologyMap) and used by pharmaceutical companies, biotechnology firms, and academic institutions globally.
Companies that use AIRA MATRIX
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles4 records
AIRA MATRIX technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature1 record
AIRA MATRIX partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- HistowizcoreAIRA Matrix provides AI tools that are integrated into Histowiz's PathologyMap platform. PathologyMap is an AI-enabled digital pathology platform that achieves over 98% accuracy in automated quality control for pathology slides. The partnership makes AIRA Matrix's AI tools available to pharma, biotech and academic institutions globally through Histowiz's platform.
Scale indicators1 record
Recent moves3 records
Expansion highlights4 records
AIRA MATRIX competitors and assessment
Company assessmentDirect peers
- PathAI: PathAI develops AI-powered pathology solutions for cancer diagnosis and biomarker analysis. It is a direct competitor to AIRA Matrix, serving pharma, biotech, and clinical labs with similar computational pathology capabilities.
- Paige.AI: Paige builds AI for digital pathology with a focus on cancer detection and clinical-grade diagnostics. It is a direct pathology AI competitor targeting similar pharma and clinical customer segments as AIRA Matrix.
- Owkin: Owkin applies AI to pathology and biomedical research for pharma and biotech clients. It overlaps directly with AIRA Matrix's pathology AI offering for pharma/biotech R&D use cases.
- Ibex Medical Analytics: Ibex provides AI-based cancer diagnostics for pathology labs and health systems. It is a direct peer in applying computer vision to pathology slides for diagnostic decision support.
- Proscia: Proscia is a digital pathology platform that embeds AI applications for pathology workflows. It is comparable because it operates both as a platform and an AI provider in the same ecosystem AIRA Matrix serves via Histowiz.
- Visiopharm: Visiopharm delivers image analysis and AI solutions for quantitative pathology. It targets pharma and research labs with similar AI-driven pathology tools, making it a direct comparability peer.
- Indica Labs: Indica Labs produces image analysis software for digital pathology, including AI-based workflows. It competes in the same pathology AI/image analysis space as AIRA Matrix for pharma and research customers.
Emerging players
- Lumea: Lumea is a digital pathology platform that has recognized AIRA Matrix as a top AI partner. It is an adjacent ecosystem participant whose platform could become a distribution channel similar to Histowiz.
Broad incumbents
- Roche (Ventana): Roche, through Ventana, is a broad incumbent in pathology diagnostics, including digital pathology and AI-enabled image analysis. It is comparable as a large-scale player overlapping with AIRA Matrix's customer base in clinical and pharma pathology.
- Leica Biosystems (Danaher): Leica Biosystems provides digital pathology platforms and image management solutions used by pathology labs globally. It is a broad incumbent comparable to the platform ecosystem in which AIRA Matrix's AI is embedded.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
AIRA MATRIX social profiles
Digital presenceAIRA MATRIX financial estimates
Financial estimateRevenue estimate
Valuation estimate
AIRA MATRIX leadership team
Management profileNumber of profiles
Profiles4 records
AIRA MATRIX funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AIRA MATRIX M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AIRA MATRIX
What does AIRA MATRIX do?
AIRA Matrix develops and licenses AI-powered image analysis and management software for digital pathology and preclinical toxicology. Its core product consists of AI diagnostic tools that automate quality control and support cancer and disease detection on pathology slides, achieving over 98% accuracy. The tools are delivered through an OEM/embedded model into third-party digital pathology platforms such as Histowiz's PathologyMap, making them available to pharmaceutical companies, biotechnology firms, and academic institutions globally.
Is AIRA MATRIX a public or private company?
AIRA MATRIX is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was AIRA MATRIX founded?
AIRA MATRIX was founded in 2011. It employs 101 to 250 people.
Where is AIRA MATRIX based?
AIRA MATRIX is headquartered in Thane, India, in the Asia region.
How does AIRA MATRIX make money?
One revenue line is on record: AI Technology Licensing and OEM Integration.
Who are AIRA MATRIX's main competitors?
Direct peers on record are PathAI, Paige.AI, Owkin, Ibex Medical Analytics, Proscia, Visiopharm and Indica Labs. Lumea is listed as an emerging player. Broad incumbents are Roche (Ventana) and Leica Biosystems (Danaher).
Does AIRA MATRIX have an API?
No public API is recorded for AIRA MATRIX.
What industry is AIRA MATRIX in?
AIRA MATRIX's product category is Digital Pathology AI Software. Its primary akta.pro industry code is HLAAALAO, Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays), with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 51321 and its SIC code is 2835.